Bill Warren, partner with the law firm Eversheds Sutherland and chair of its biotechnology and life sciences team, discusses the ruling by a three-judge panel of the Patent Trial and Appeal Board siding with the Broad Institute of MIT and Harvard in the bitter legal battle over who invented CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology.

Previous articleEpithelial Cells Put on the Rack to Extract Turnover Secrets
Next articleCapricor Drops Cenderitide to Focus on Cell and Exosome Therapies